- Home
- Antimicrobial Susceptibility Testing Market

Global Antimicrobial Susceptibility Testing Market - Indsutry Trends and Forecast to 2028
- Published Date: September, 2022 | Report ID: CLS-58 | No of pages: 388 | Format:
Global antimicrobial susceptibility testing market is projected to register a substantial CAGR of 5.7% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.
Market Segmentation:
Global Antimicrobial Susceptibility Testing Market, By Product Type (Instruments, Consumables & Accessories and Services & Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods and Others), Type (Antibacterial Testing, Antifungal Testing and Others), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others), End User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres & Academic Institutes and Others), Distribution Channel (Direct Sales, Retail Sales and Third Party Distributor),Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil and rest of South America, South Africa and rest of Middle East and Africa) Industry Trends & Forecast to 2028
Some of the major factors contributing to the growth of the antimicrobial susceptibility testing market are:
Rise in epidemic and pandemic events
Growing technological advancements
Market Players:
The key market players for global wearable electronic devices market are listed below:
BD
Synbiosis
Zhuhai DL Biotech Co., Ltd
Mast Group Ltd.
HiMedia Laboratories
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Creative Diagnostics
Genefluidics, Inc.
Rosco Diagnostica A/S
ERBA Group
Liofilchem S.r.l.
Alifax S.r.l.
MERLIN Gesellschaft fr mikrobiologische Diagnostika mbH
bioMrieux SA
Merck KGaA
Danaher
Accelerate Diagnostics, Inc.
NuMedii, Inc.
BacterioScan, Inc.
TABLE OF CONTENT
Segmentation
Short Description
Global Antimicrobial Susceptibility Testing Market, By Product Type (Instruments, Consumables & Accessories and Services & Software), Methods (Mass Spectrometry Method, Dilution, Disk Diffusion, E-Test, Genotypic Methods and Others), Type (Antibacterial Testing, Antifungal Testing and Others), Application (Clinical Diagnostics, Drug Discovery and Development, Epidemiology and Others), End User (Hospitals, Pharmaceuticals and Biotechnology Companies, Diagnostic Laboratories, Contract Research Organizations, Research Centres & Academic Institutes and Others), Distribution Channel (Direct Sales, Retail Sales and Third Party Distributor),Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Belgium, Turkey and rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and rest of Asia-Pacific, Brazil and rest of South America, South Africa and rest of Middle East and Africa) Industry Trends & Forecast to 2028
Market Definition:
Antimicrobial susceptibility testing (AST) is a laboratory procedure which is used to determine which antimicrobial impedes the growth of bacteria, fungi and other microorganism causing a specific infection. Susceptibility testing is performed on microorganisms such as bacteria and fungi causing the infection after they have been recovered in a culture of the specimen. With the rise in pandemic and epidemic situations around the globe, large numbers of diseases are also transmitting from person to person which is propelling the demand for antimicrobial susceptibility testing and is acting as a driver for the antimicrobial susceptibility testing market.
Market Segmentation:
The antimicrobial susceptibility testing market is categorized into six notable segments which are based on the product type, methods, type, application, end user and distribution channel.
On the basis of product type, the antimicrobial susceptibility testing market is segmented into instruments, consumables & accessories and services & software
On the basis of methods, the antimicrobial susceptibility testing market is segmented into mass spectrometry method, dilution, disk diffusion, e-test, genotypic methods and others
On the basis of type, the antimicrobial susceptibility testing market is segmented into antibacterial testing, antifungal testing and others
On the basis of application, the antimicrobial susceptibility testing market is segmented into clinical diagnostics, drug discovery and development, epidemiology and others
On the basis of end user, the antimicrobial susceptibility testing market is segmented into hospitals, pharmaceuticals and biotechnology companies, diagnostic laboratories, contract research organizations, research centres & academic institutes and others
On the basis of distribution channel, the antimicrobial susceptibility testing market is segmented into direct sales, retail sales and third party distributor
Market Players
The key market players for global antimicrobial susceptibility testing market are listed below:
BD
Synbiosis
Zhuhai DL Biotech Co., Ltd
Mast Group Ltd.
HiMedia Laboratories
Thermo Fisher Scientific Inc.
Bio-Rad Laboratories, Inc.
Creative Diagnostics
Genefluidics, Inc.
Rosco Diagnostica A/S
ERBA Group
Liofilchem S.r.l.
Alifax S.r.l.
MERLIN Gesellschaft fr mikrobiologische Diagnostika mbH
bioMrieux SA
Merck KGaA
Danaher
Accelerate Diagnostics, Inc.
NuMedii, Inc.
BacterioScan, Inc.
Methodology
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
© 2025 Cognate Lifesciences. All Rights Reserved.